Bank of Montreal’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-29,000
Closed -$4.75M 4042
2022
Q1
$4.75M Buy
+29,000
New +$4.21M ﹤0.01% 1524
2019
Q2
Sell
-15,000
Closed -$1.21M 4830
2019
Q1
$1.21M Buy
15,000
+10,000
+200% +$818K ﹤0.01% 1949
2018
Q4
$461K Buy
+5,000
New +$440K ﹤0.01% 2205

Other funds holding ABBV

Bank of Montreal's ABBV Position: Q1 2026 in Review

Bank of Montreal reduced its AbbVie (ABBV) stake by 4.4% in Q1 2026, selling an estimated $31.7M and leaving 3,078,495 shares worth $670M. The position accounts for 0.25% of the portfolio, ranked #74.

Bank of Montreal first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $793M in Q3 2024. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bank of Montreal held 3,078,495 shares of AbbVie worth $670M as of Q1 2026.
  • Bank of Montreal sold 142,726 AbbVie shares in Q1 2026, an estimated $31.7M.
  • AbbVie made up 0.25% of Bank of Montreal's portfolio in Q1 2026, its #74 holding.
  • Bank of Montreal first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's AbbVie position peaked at $793M in Q3 2024.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.